PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models
2017 · Molecular Cancer · 69 citations
https://doi.org/10.1186/s12943-017-0652-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
690
Citations
9
h-index
9
i10-index
Federica Capozzi is an academic researcher from University of Campania "Luigi Vanvitelli". The author has contributed to research in topics: PARP inhibition in cancer therapy & Sarcoma Diagnosis and Treatment & PI3K/AKT/mTOR signaling in cancer. The author has an h-index of 9, co-authored 28 publications.
ORCID: 0000-0002-6458-5699https://doi.org/10.1186/s12943-017-0652-5
https://doi.org/10.1007/s00262-025-04141-w
Click to start Chat